IP Verse

Sorbonne Universit patent opposition analysis

CompanyCompetitive AnalysisCompany Patent Opposition Analysis

Latest patents of Sorbonne Universit opposed by its competitors

Explore Sorbonne Universit's recently opposed patents, revealing key competitive challenges and strategic patent disputes in the industry. Track oppositions filed by competitors to understand technology battlegrounds and assess potential risks.

Last updated on: Aug 7, 2025
Patent NumberGrant DateTitleTotal Oppositions
EP3920970
Nov 23, 2022Method For Treating Checkpoint Inhibitors Induced Adverse Events1
EP3096781
Nov 2, 2022Agents For Use In The Treatment Of Retinal Inflammation1
EP3768304
Oct 12, 2022Compositions And Methods For Increasing Or Enhancing Transduction Of Gene Therapy Vectors And For Removing Or Reducing Immunoglobulins6
EP3116529
Oct 27, 2021Interleukin-2 For Treating Food Allergy1
EP3212200
Jan 20, 2021Use Of A Reverse-Transcriptase Inhibitor In The Prevention And Treatment Of Degenerative Diseases1
EP3443979
May 27, 2020Il-2 Dosage Regimen For Treating Systemic Lupus Erythematosus1
EP2790706
May 8, 2019Phytoecdysones For Use In Improving The Muscle Quality Of Obese And/Or Sarcopenic Mammals1
EP2683395
Aug 1, 2018Use Of Low Dose Il-2 For Treating Autoimmune - Related Or Inflammatory Disorders1

Top competitors of Sorbonne Universit

List of top competitors of Sorbonne Universit based on patent oppositions.